Table 3 Pearson correlation coefficients between AT lipolysis, AT size and AT immunophenotype of subcutaneous and visceral AT depots and whole-body IR.
Subcutaneous AT | R | p value | Visceral AT | R | p value |
|---|---|---|---|---|---|
Basal lipolysis, µmol glycerol (3 h) per 10^6 cells | 0.525 | 0.002 | Basal lipolysis, µmol glycerol (3 h) per 10^6 cells | 0.118 | 0.514 |
Isoprenaline responsiveness, fold change to basal | −0.242 | 0.175 | Isoprenaline responsiveness, fold change to basal | −0.290 | 0.102 |
ANP responsiveness, fold change to basal | −0.237 | 0.184 | ANP responsiveness, fold change to basal | −0.167 | 0.361 |
Adipocyte diameter, µm | 0.472 | 0.004 | Adipocyte diameter, µm | 0.652 | <0.001 |
Total CD45+ leukocytes, % of total cells | 0.192 | 0.234 | Total CD45+ leukocytes, % of total cells | 0.514 | 0.001 |
CD3+ T cells, % of total cells | 0.381 | 0.018 | CD3+ T cells, % of live cells | 0.166 | 0.300 |
CD3+ CD4+ T-helper cells, % of total cells | 0.204 | 0.219 | CD3+ CD4+ T-helper cells, % of total cells | 0.016 | 0.923 |
CD3+ CD8+ cytotoxic T cells, % of total cells | 0.499 | 0.001 | CD3+ CD8+ cytotoxic T cells, % of total cells | 0.290 | 0.069 |
CD4+/CD8+ T cell ratio | −0.095 | 0.570 | CD4+/CD8+ T cell ratio | −0.128 | 0.431 |
CD56+ NK cells, % of total cells | 0.442 | 0.005 | CD56+ NK cells, % of total cells | 0.206 | 0.196 |
CD11c+ M1 macrophages, % of total cells | 0.086 | 0.598 | CD11c+ M1 macrophages, % of total cells | 0.243 | 0.127 |
CD11c− M2 macrophages, % of total cells | −0.105 | 0.521 | CD11c- M2 macrophages, % of total cells | 0.195 | 0.221 |
M1/M2 ratio | 0.060 | 0.715 | M1/M2 ratio | 0.078 | 0.626 |
CD19+ B lymphocytes, % of total cells | 0.047 | 0.778 | CD19+ B lymphocytes, % of total cells | 0.332 | 0.034 |
